Curtis Oltmans has been appointed General Counsel, Array BioPharma. Mr. Oltmans brings 25 years of experience in the biopharmaceutical industry working on legal matters related to commercialization, litigation, medical, regulatory affairs, intellectual property, corporate governance, mergers and acquisitions, strategic alliances and financial transactions. His appointment will support Array’s efforts as it moves towards potential commercialization.  Mr. Oltmans most recently served as c...